General | Node negative | Node Positive | Clin / Path features | Role Plays |
---|---|---|---|---|
RT-PCR
How is the technique used for ODX test processing?
|
What are the validation studies in N0 setting?
What are the validation studies in N0 setting?
|
What are the node positive studies?
TransATAC SWOG RxPONDER
What are the node positive studies?
|
Grade 1, size >3 Grade 2, size >2 Grade 3, size >3
What is the definition of clinical High risk in TAILORx?
|
TailorX
Newbie - N0
|
21 genes
How many genes is the panel of ODX? |
28%
What is the absolute chemotherapy benefit in B20?
|
inclusion of the age and relevance to CT benefit in primary endpoint ARM A & D excluded from the study Pre-defined cut points for menopausal status no statistical significant iDFS difference between two subgroups
Name 2 differences between TAILORx and RxPONDER
|
43%
What is the percentage of patients that presented with high clinical risk but fell in low risk category with ODX - TAILORx?
|
RxPONDER
RxPONDER
Newbie - N1 |
Level 1b
What is the level of ODX data in NSABP-B20? |
6.5%
For a RS of 23 for a pre-menopausal women, what is the CT benefit?
|
2.9%
What is the benefit of CT for pre-menopausal women in RxPONDER
|
N0/ N1 post-menopausal , more than 0.5 cm
Who is eligible for ODX according to NCCN guidelines? |
Patient centricity
Patient centricity
User - N0 Clinical path features (general) |
What is the level of ODX data after RxPONDER and TailorX?
Level 1a
What is the level of ODX data after RxPONDER and TailorX?
|
13%
What is the distance recurrence rate for the ARM D in TAILORx?
|
How is menopausal status defined in RxPONDER?
pre-menopausal: less than 6 months since the last period post-menopausal: more than 12 month since last period
How is menopausal status defined in RxPONDER?
|
No longer put to vote - not recommended
Where does St Gallen stands when it comes to incorporation of ki-67 in treatment paradigm |
patient centricity
patient centricity
ki-67 driver for ODX prescription USER |
1-10
According to the 8th pathologist association criteria, which RS range recategorizes the patient from stage 2 to stage 1
|
Primary: IDFS
Secondary: OS, DRFI
Primary: IDFS
Secondary: OS, DRFI What are the primary and secondary endpoints in TAILORx? |
Primary: iDFS with adjustment in menopausal status
Secondary: OS
What are the endpoints in RxPONDER?
|
Node status
Ki-67 Age Tumor Size Grade Clinical H/L All
In the German study what were the stratification of patients
|
:)
Oncotype is not for everyone as it is expensive
|